% Expired Patents = 40.0

EPO Patents = 1

Forward Citations = 174

Loading Chart...

7 inventors (with patents filed for the assignee):

Lisa McKerracher (5 out of 6 patents)

Eryk Thouin (1 out of 3 patents)

Robert A Snow (1 out of 40 patents)

4. William D Lubell (1 out of 2 patents)

5. Jon Scott Munzer (1 out of 1 patent)

6. Karine Gingras (1 out of 1 patent)

7. Dana Lasko (1 out of 1 patent)

8. Lisa Mckerracher (0 patent)

5 patents: Sort by Forward Citations

1. 7910554 - Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions (2011-03-22),

2. 7795218 - ADP-ribosyl transferase fusion variant proteins (2010-09-14),

3. 7572913 - 4-substituted piperidine derivatives (2009-08-11),

4. 7442686 - Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions (2008-10-28),

5. 6855688 - ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use (2005-02-15),

Company Overview

Bioaxone Therapeutique Inc. is a biotechnology company focused on the development of innovative therapeutics for the treatment of spinal cord injuries and neurodegenerative diseases. The company utilizes cutting-edge technologies and approaches to discover and advance novel drug candidates with the ultimate goal of improving the lives of patients suffering from these debilitating conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#200 in Montreal

#2,851 in Canada

Montreal, Canada

Bioaxone Therapeutique Inc.

Forward Citations = 174

7 inventors:

Lisa McKerracher (5 out of 6 patents)

Eryk Thouin (1 out of 3 patents)

Robert A Snow (1 out of 40 patents)

4. William D Lubell (1 out of 2 patents)

5. Jon Scott Munzer (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioaxone Therapeutique Inc.. Retrieved from https://idiyas.com/company/bioaxone-therapeutique

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]